Search

Search Results

• PO042 | ACQUIRED HEMOPHILIA A AND ANTIPHOSPHOLIPID SYNDROME: CONCURRENCY OR OVERLAPPING? E. Galimberti¹, C. Ambaglio¹, T. Zollner¹, F. Schieppati^1|2, O.C. Cretu¹, F. Zunino¹, V. Brusegan¹, M. Marchetti^1|2, A. Falanga^1|2, L. Barcella¹ | ¹Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ERN-EuroBloodNet - European Reference Network in Rare Hematological Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  Elisa Galimberti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.858

  25

  PDF: 8

• CO08 | The utility of urine qualitative assessment for direct oral anticoagulants in routine clinical practice F. Schieppati^1,2, P. Gomez-Rosas^1,3, C. Ambaglio¹, V. Brusegan¹, Oc. Cretu^1,2, E. Galimberti¹, F. Zunino¹, L. Barcella¹, J. Harenberg^4,5, A. Falanga^1,2, M. Marchetti^1,2 | ¹Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; ⁴Ruprecht Karls University of Heidelberg, Germany; ⁵Germany DOASENSE GmbH, Heidelberg, Germany

  22-10-2025

  https://doi.org/10.4081/btvb.2025.212

  749

  PDF: 21

• CO044 | QUALITY AND SAFETY OF VITAMIN K ANTAGONIST TREATMENT IN PEDIATRIC PATIENTS: A RETROSPECTIVE CLINICAL AUDIT FROM A SINGLE CENTER C. Ambaglio¹, T. Zollner¹, G. Cuni¹, S. Bolognini¹, C. Ticozzi¹, F. Schieppati¹, E. Galimberti¹, O.C. Cretu¹, V. Brusegan¹, F. Zunino¹, F. Duca², M. Marchetti¹, A. Falanga^1|2, L. Barcella¹ | ¹Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ERN-EuroBloodNet - European Reference Network in Rare Hematological Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  Chiara Ambaglio

  26-10-2026

  https://doi.org/10.4081/btvb.2026.746

  23

  PDF: 9
• 

  PO27 | URINE QUALITATIVE ASSESSMENT OF DIRECT ORAL ANTICOAGULANTS IN ROUTINE CLINICAL PRACTICE F. Schieppati^1|2, P. Gomez-Rosas^1|3, C. Ambaglio¹, V. Brusegan¹, O.C. Cretu¹, E. Galimberti¹, F. Zunino¹, L. Barcella¹, J. Harenberg^4|5, A. Falanga^1|2, M. Marchetti^1|2 | ¹Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; ⁴Ruprecht Karls University of Heidelberg, Heidelberg, Germany; ⁵DOASENSE GmbH, Heidelberg, Germany

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.522

  454

  PDF: 96

• CO066 | COAGULOPATHY IN CAR-T CELL-TREATED PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS: A RETROSPECTIVE, SINGLE-CENTER OBSERVATIONAL STUDY I. Santo¹, R. Morganti², G. Leoni³, G. Tancredi³, L. Contino⁴, S. Galimberti³, R.M. Santi⁴, E. Orciuolo⁵ | ¹Azienda Toscana Nord Ovest, Versilia Hospital, Italy; ²Hematology Division AOUP, Pisa, Italy; ³University of Pisa, Hematology Pisa, Italy; ⁴Azienda Ospedaliera Universitaria Alessandria, Italy; ⁵Azienda Ospedaliera Universitaria Pisana, Hematology Pisa, Italy

  Ignazio Santo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.768

  31

  PDF: 9
• 

  PO23 | IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA RELATED TO DELAYED IMMUNE CHECKPOINT INHIBITORS TOXICITY: A CASE REPORT E. Galimberti¹, F. Schieppati¹, C. Ambaglio¹, M. Marchetti¹, L. Barcella¹, A. Falanga^1|2 | ¹Immunohematology and Transfusion Medicine Unit, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milan-Bicocca, Milano, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.518

  418

  PDF: 85

• CO035 | THE ROLE OF INFLAMMATORY BIOMARKERS IN IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA F. Schieppati^1|2, S. Bolognini^1|2, C. Ticozzi¹, O.C. Cretu¹, P. Gomez-Rosas^1|3, M. D’Adda⁴, V. Cancelli⁴, C. Ambaglio¹, E. Galimberti¹, L. Barcella¹, A. Falanga^1|2, M. Marchetti^1|2 | ¹Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ERN-EuroBloodNet - European Reference Network in Rare Hematological Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; ⁴Hematology, Hospital Spedali Civili di Brescia, Brescia, Italy

  Francesca Schieppati

  26-10-2026

  https://doi.org/10.4081/btvb.2026.737

  28

  PDF: 10
• 

  PO60 | VEXAS SYNDROME AS A NEW SEVERE THROMBOPHILIC CLONAL CONDITION: A SINGLE CENTRE EXPERIENCE C. Ambaglio¹, E. Galimberti¹, F. Schieppati¹, M. Frigeni², M. Marchetti¹, L. Barcella¹, A. Falanga ^1|3 | ¹Immunohematology and Transfusion Medicine Unit, ASST Papa Giovanni XXIII, Bergamo; ²Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo; ³School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.551

  506

  PDF: 110

• PO150 | FACTOR XII DEFICIENCY IN THE SETTING OF RECURRENT THROMBOSIS AND EXTENDED VENOUS OBSTRUCTION: A CASE ANALYSIS L. Leoni¹, G. Pata¹, A. Domenighini¹, L. Crippa², T. D'aliberti¹, G. Galimberti¹, F. Paciullo¹, P. Rovere Querini¹ | ¹Internal Medicine Unit; ²Coagulation Service Thrombosis Research Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

  Laura Leoni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.966

  21

  PDF: 7

• PO089 | A RISK-ADAPTED, MULTIDISCIPLINARY CONSENSUS FOR ADULT ITP MANAGEMENT: BRIDGING GUIDELINES AND REAL-WORLD PRACTICE A. Votto¹, E. Pacini², G. Giustini³, I. Rina¹, S. Galimberti¹ | ¹Department of Clinical and Experimental Medicine, University of Pisa, Italy; ²Hematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese, Italy; ³Hematology Unit, AOU Careggi, Firenze, Italy

  Amedeo Votto

  26-10-2026

  https://doi.org/10.4081/btvb.2026.905

  21

  PDF: 6

• CO043 | LONG TERM TREATMENT WITH VITAMIN K ANTAGONIST IN PEDIATRIC PATIENTS WITH PROSTHETIC HEART VALVE: THE BERGAMO EXPERIENCE T. Zollner¹, C. Ambaglio¹, F. Duca², G. Cuni¹, E. Galimberti¹, O.C. Cretu¹, F. Schieppati¹, F. Zunino¹, V. Brusegan¹, M. Marchetti¹, A. Falanga^1|2, L. Barcella¹ | ¹Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ERN-EuroBloodNet - European Reference Network in Rare Hematological Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  Chiara Ambaglio

  26-10-2026

  https://doi.org/10.4081/btvb.2026.745

  24

  PDF: 9